ISSN: 1757-4676

Journal Home

EMBO Molecular Medicine Q1 Unclaimed

Springer United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

EMBO Molecular Medicine is a journal indexed in SJR in Molecular Medicine with an H index of 142. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 3300 €. The scope of the journal is focused on molecular medicine, molecular pathology, genetic processes, regenerative medicine, systems medicine, molecular biology. It has an SJR impact factor of 3,964 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,964.

EMBO Molecular Medicine focuses its scope in these topics and keywords: als, ftd, cell, approach, spectrum, vulnerability, phenotypes, proteomic, resolves, network, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Molecular Medicine (Q1)

Price

3300 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

3,964

SJR Impact factor

142

H Index

165

Total Docs (Last Year)

440

Total Docs (3 years)

9076

Total Refs

3842

Total Cites (3 years)

381

Citable Docs (3 years)

8.2

Cites/Doc (2 years)

55.01

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Cancer Q1
Pharmacological Reviews Q1
Genome Medicine Q1
Polish Botanical Journa-Plant Fungal and Sistematics Q1
Molecular Therapy Q1

Compare this journals

Aims and Scope

Best articles by citations

PHD

Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem

VEGF

Microparticle alpha-2-macroglobulin enhances pro-resolving responses and promotes survival in sepsis

Inhibiting MARSs reduces hyperhomocysteinemia-associated neural tube and congenital heart defects

Triggering ubiquitination of

A streptococcal lipid toxin induces membrane permeabilization and pyroptosis leading to fetal injury

Fusion protein of retinol-binding protein and albumin domain

Block of K

Acquisition of chromosome instability is a mechanism to evade oncogene addiction

Low-dose

Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients

SHOW MORE ARTICLES

Inducing mitophagy in diabetic platelets protects against severe oxidative stress

Alterations in cardiac DNA methylation in human dilated cardiomyopathy

Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response

Genome-wide identification and functional analyses of micro

STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy

Anti-tumor effects of

Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway

Innovation and competition in advanced therapy medicinal products

A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases

ZNF703gene amplification at 8p12 specifies luminal B breast cancer

Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization